Clinical Trial Update: Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 clinical trial investigating the combination of daratumumab and ibrutinib to treat symptomatic chronic lymphocytic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Daratumumab (daratumumab)
• Ibrutinib (ibrutinib)

Snippet

Sponsor: Jennifer Woyach | Conditions: Chronic Lymphocytic Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING